1.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NA_00041916, NCT01416025
|
|
2.
|
Phase: Phase III Type: Supportive care Status: Active Age: 15 and younger Sponsor: Other Protocol IDs: antifungal prophylaxis, Dr. SAMEER BAKHSHI, NCT00624143
|
|
3.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VORI911, NCT00893555
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 9766-CL-0104, WSA-CS-004, 2006-003868-59, NCT00412893
|
|
5.
|
Phase: Phase III Type: Supportive care, Treatment Status: Approved-not yet active Age: 3 months to 20 years Sponsor: NCI Protocol IDs: COG-ACCL1131, ACCL1131, NCT01503515
|
|
6.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 2 to 15 Sponsor: Pharmaceutical / Industry Protocol IDs: A1501096, NCT01383993
|
|
7.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 to 55 Sponsor: Other Protocol IDs: RJH-2011-71, NCT01501708
|
|
8.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Active Age: 8 and over Sponsor: NCI Protocol IDs: NCI-06-C-0198, NCI-P6963, NCT00411008
|
|
9.
|
Phase: No phase specified Type: Supportive care Status: Active Age: 15 to 65 Sponsor: Other Protocol IDs: VCZ_TDM_Korea, NCT00673348
|
|
10.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Active Age: 15 and over Sponsor: Other Protocol IDs: VCZ-IPA-HEM-2010, NCT01148160
|